Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
6.83
-0.19 (-2.71%)
At close: Sep 15, 2025, 4:00 PM EDT
6.79
-0.04 (-0.56%)
After-hours: Sep 15, 2025, 5:55 PM EDT
Kamada Revenue
Kamada had revenue of $44.75M in the quarter ending June 30, 2025, with 5.37% growth. This brings the company's revenue in the last twelve months to $169.52M, up 9.67% year-over-year. In the year 2024, Kamada had annual revenue of $160.95M with 12.93% growth.
Revenue (ttm)
$169.52M
Revenue Growth
+9.67%
P/S Ratio
2.32
Revenue / Employee
$403,612
Employees
420
Market Cap
394.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
KMDA News
- 19 days ago - Kamada: Earnings Expansion Cycle With Embedded Margin Of Safety - Seeking Alpha
- 4 weeks ago - Kamada Ltd. (KMDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - GlobeNewsWire
- 3 months ago - Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East - GlobeNewsWire
- 4 months ago - Kamada Ltd. (KMDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability - GlobeNewsWire
- 6 months ago - Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas - GlobeNewsWire
- 6 months ago - Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript - Seeking Alpha